Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia.

about

Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q47134267

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@en

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@nl

type

Item

label

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@en

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@nl

prefLabel

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@en

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@nl

P1476

Gene-body hypermethylation con ...... chronic lymphocytic leukemia.

@en

P2093

Chandrasekhar Kanduri

http://www.w3.org/2001/XMLSchema#string

Meena Kanduri

http://www.w3.org/2001/XMLSchema#string

Mohammad Hamdy Abdelrazak Morsy

http://www.w3.org/2001/XMLSchema#string

Pradeep Kumar Kopparapu

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Functions of TET Proteins in Hematopoietic Transformation

Mechanism and function of oxidative reversal of DNA and RNA methylation

Characterization of 4 mantle cell lymphoma cell lines

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

Functions of DNA methylation: islands, start sites, gene bodies and beyond

Conserved role of intragenic DNA methylation in regulating alternative promoters

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

P304

77595-77608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20668

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29100411

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5652802

http://www.w3.org/2001/XMLSchema#string